Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab
Sundaram Balasubramanian, T Nagendran, Bala Ramachandran, Athimalaipet V Ramanan
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)MedicineAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyImmunoglobulin GImmunologyIntravenous ImmunoglobulinsInternal medicineOutbreakInfectious disease (medical specialty)Rheumatoid arthritisDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders